These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5002767)

  • 41. [Antibodies recognizing some IgM immunoglobulins in multitransfused patients (author's transl)].
    Ropars C; Whylie S; Cartron J; Doinel C; Gerbal A; Salmon C
    Nouv Rev Fr Hematol; 1973; 13(4):459-67. PubMed ID: 4127834
    [No Abstract]   [Full Text] [Related]  

  • 42. SUCCESSFUL PREVENTION OF EXPERIMENTAL RH SENSITIZATION IN MAN WITH AN ANTI-RH GAMMA2-GLOBULIN ANTIBODY PREPARATION: A PRELIMINARY REPORT.
    FREDA VJ; GORMAN JG; POLLACK W
    Transfusion; 1964; 4():26-32. PubMed ID: 14105934
    [No Abstract]   [Full Text] [Related]  

  • 43. [Demonstrating serum anti-gamma globulin factors with erythrocytes sensitized by Vi-polysaccharides and anti-D-complete serum].
    Toshkov A; Shirova L
    Izv Mikrobiol Inst (Sofiia); 1969; 20():165-70. PubMed ID: 5312368
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of white cell and red cell antibodies in human sera.
    Ross JM; James DC
    J Clin Pathol; 1973 May; 26(5):367-70. PubMed ID: 4197543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rare blood factor Du].
    Piskunova TM
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):3-9. PubMed ID: 4206510
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevention of Rh immunization after transfusion with Rh-positive blood.
    McElrath TG; Ascari WQ
    Am J Obstet Gynecol; 1971 Jun; 110(3):309-10. PubMed ID: 4103592
    [No Abstract]   [Full Text] [Related]  

  • 47. Agglutinins for "null" red blood cells.
    McGinniss MH; Kaplan HS; Bowen AB; Schmidt PJ
    Transfusion; 1969; 9(1):40-2. PubMed ID: 4973876
    [No Abstract]   [Full Text] [Related]  

  • 48. Antibodies to IGA in pregnancy and in recipient of Rh o (D) immune globulin (human).
    Pai MK; Zipursky A; Vyas GN
    Transfusion; 1972; 12(6):394-9. PubMed ID: 4629999
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of anti-Rh(D) immunoglobulin for the presence of antibodies with different properties].
    Kuśnierz G; Walewska I; Maczyńska-Rusiniak B; Kacperska E; Głoskowska Z; Madaliński K
    Acta Haematol Pol; 1977; 8(4):281-7. PubMed ID: 415481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crossmatch difficulties following the prophylactic use of Rh immune globulin.
    Wright J; Freedman J; Lim FC; Garvey MB
    Can Med Assoc J; 1979 May; 120(10):1235-8. PubMed ID: 109179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On certain properties of antisera prepared against human serum and its various protein fractions; their use in the detection of sensitisation of human red cells with incomplete Rh antibody, and on the nature of this antibody.
    COOMBS RR; MOURANT AE
    J Pathol Bacteriol; 1947; 59(1-2):105-11. PubMed ID: 20266353
    [No Abstract]   [Full Text] [Related]  

  • 52. Radioelectroimmunoassay of anti-D immunoglobulin on agarose plates containing whole red cells.
    Eriksson O; Enell B
    Vox Sang; 1976; 31(1):13-24. PubMed ID: 820077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood.
    Pollack W; Ascari WQ; Crispen JF; O'Connor RR; Ho TY
    Transfusion; 1971; 11(6):340-4. PubMed ID: 5002766
    [No Abstract]   [Full Text] [Related]  

  • 54. EVOLUTION OF THE ANTI-GM SUBSTANCES AND OF THE REACTIVITY OF RHEUMATOID SERA FOR HUMAN RED CELLS SENSITIZED WITH 3 DIFFERENT ANTI-RH SERA OR IMMUNE RABBIT SERA AND FOR F. II LATEX.
    JACQUELINE F; PODLIACHOUK L; EYQUEM A
    Arthritis Rheum; 1964 Apr; 7():110-8. PubMed ID: 14150740
    [No Abstract]   [Full Text] [Related]  

  • 55. A new method of antibody elution from red blood cells.
    Chan-Shu SA; Blair O
    Transfusion; 1979; 19(2):182-5. PubMed ID: 107629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Formation of anti-gamma globulin antibodies in infants treated with gamma globulin for therapeutic purposes].
    Bardare M
    Minerva Pediatr; 1967 Feb; 19(8):366-8. PubMed ID: 4176408
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunosuppression of anti-Rh antibodies: mechanism of action and times of administration of the anti-D immunoglobulins].
    Carretti N
    Attual Ostet Ginecol; 1968; 1():181-92. PubMed ID: 4194920
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum IgG, IgA, IgM and antigamma globulin factor levels in normal parturients and parturients with Rh incompatibility].
    Noeva K; Toshkov A; Prodanov P
    Acta Microbiol Virol Immunol (Sofiia); 1977; 5():65-71. PubMed ID: 416658
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention of maternal sensitization to the Rh factor.
    N Engl J Med; 1972 Jul; 287(4):197-8. PubMed ID: 4624455
    [No Abstract]   [Full Text] [Related]  

  • 60. The transfusion of Rh-positive blood into Rh-negative women.
    Keith L; Berger GS; Pollack W
    Am J Obstet Gynecol; 1976 Jun; 125(4):502-6. PubMed ID: 824954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.